Cellbricks TherapeuticsCellbricks Therapeutics
CT

Cellbricks Therapeutics

Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.

Active
Advertise here

About

Cellbricks Therapeutics is a Berlin-founded biotech startup focused on developing a proprietary biofabrication platform for creating vascularized human tissue implants. Their technology combines human cells with biomaterials to produce tissue constructs for implantation, initially targeting soft tissue loss, complex wounds, and reconstructive defects. The company's long-term vision is to build the capabilities for manufacturing fully functional, implantable human organs. Their platform utilizes a light-based bioprinting process that allows for high-speed production of large, viable, and vascularized tissue constructs.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Cellbricks Therapeutics do?

Cellbricks Therapeutics is a Berlin-founded biotech startup focused on developing a proprietary biofabrication platform for creating vascularized human tissue implants. Their technology combines human cells with biomaterials to produce tissue constructs for implantation, initially targeting soft tissue loss, complex wounds, and reconstructive defects. The company's long-term vision is to build the capabilities for manufacturing fully functional, implantable human organs. Their platform utilizes…

How much funding has Cellbricks Therapeutics raised?

Cellbricks Therapeutics has raised a total of $7M in funding. The most recent round on record is Seed.

Where is Cellbricks Therapeutics headquartered?

Cellbricks Therapeutics is headquartered in Berlin, Germany.

What industry does Cellbricks Therapeutics operate in?

Cellbricks Therapeutics operates in Biotechnology, Medical Devices, Regenerative Medicine, 3D Printing.